$1,259.00
In Stock
Biktarvy is intended for the treatment of HIV-1 infection in adults and children aged 6 years and older weighing at least 25 kg in the absence of any mutations associated with resistance to drugs of the integrase inhibitor class, emtricitabine or tenofovir.
Active ingredients: bictegravir 50 mg, tenofovir 25 mg and emtricitabine 200 mg;
Prescription medicine.
